1. Novo Nordisk's Victoza gets FDA okay for paediatric use  pharmaphorum
  2. Blood Sugar Control In Pediatric Patients: FDA approves first Non-Insulin Drug for Type 2 Diabetes  Specialty Medical Dialogues
  3. View full coverage on Google News
Novo Nordisk’s GLP-1 agonist Victoza has become the first non-insulin drug to be approved in the US as

Sucuri WebSite Firewall - Access Denied